Cancer News and Research

Latest Cancer News and Research

Gut microbiome may be the "black box" of nutrition research

In a recent paper published in the Cell journal, researchers at the University of Alberta, Canada, and the University College Cork, Ireland, analyzed the current nutritional guidelines for gut microbiota.

13 Jun 2022

Scientists discover novel species of betapolyomavirus in Kenya

A new study published as a pre-proof in the journal Virologica Sinica, is follow-up research to a previous study on the discovery of novel rodent viruses of various RNA viral families in Kenya.

12 Jun 2022

New machine learning algorithm finds a gene signature characteristic of tumors

How do cancer cells differ from healthy cells? A new machine learning algorithm called "ikarus" knows the answer, reports a team led by MDC bioinformatician Altuna Akalin in the journal Genome Biology. The AI program has found a gene signature characteristic of tumors.

10 Jun 2022

New statement on best practice recommendations for the care of women experiencing menopause

Best practice recommendations for healthcare professionals providing help and support to women experiencing menopause have been issued in a joint position statement from the British Menopause Society, Royal College of Obstetricians and Gynaecologists and the Society for Endocrinology.

10 Jun 2022

New molecule kills a broad spectrum of hard-to-treat cancers

A new molecule synthesized by a University of Texas at Dallas researcher kills a broad spectrum of hard-to-treat cancers, including triple-negative breast cancer, by exploiting a weakness in cells not previously targeted by other drugs.

10 Jun 2022

Androgens contribute to sex bias in bladder cancer

Male sex hormones interfere with the body's ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led by a Cedars-Sinai Cancer investigator.

10 Jun 2022

Proteomic analysis of 2002 tumors reveals 11 distinct pan-cancer molecular subtypes

A new study that analyzed protein levels in 2,002 primary tumors from 14 tissue-based cancer types identified 11 distinct molecular subtypes, providing systematic knowledge that greatly expands a searchable online database that has become a go-to platform for cancer data analysis by users worldwide.

10 Jun 2022

Stress protein in fibroblasts appears to be an attractive cancer drug target

A stress protein that is overactive in many types of tumor cells also has a key role in tumor-supporting cells called fibroblasts, and may be a good target for future cancer treatments, suggests a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.

10 Jun 2022

Using a harmless amoeba to protect children from dangerous infections

Innovative efforts at the University of Virginia School of Medicine to use a harmless amoeba to protect children from dangerous infections has won critical financial support from The Hartwell Foundation.

10 Jun 2022

Creating CAR T cells without an immune brake

T cells are usually very good at eliminating diseased cells. But they seem to fail when it comes to tumor cells.

10 Jun 2022

CDC announces first-year funding of $215 million for three national programs to prevent and control cancer

The Centers for Disease Control and Prevention today announced first-year funding awards of $215 million in a 5-year, $1.1 billion investment into three national programs to prevent and control cancer.

10 Jun 2022

Rehabilitation program via telehealth to help regional and rural women recovering from gynecological cancer

Women in rural and regional areas recovering from gynecological cancer and treatment will now have access to a University of Queensland rehabilitation program through telehealth.

10 Jun 2022

Exploring the impact of climate change on lymphedema symptoms

Flinders University studies to determine if people with lymphoedema experience symptom variations due to varying climatic conditions aim to provide better treatment outcomes for patients trying to cope with longstanding swelling in their limbs.

10 Jun 2022

Research reveals why many cancers are vulnerable to FDA-approved IDH1 inhibitors

A drug used to target IDH1 mutations in select cancers also appears to inhibit the wild-type form of the enzyme, under certain conditions.

9 Jun 2022

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines

A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors.

9 Jun 2022

Inhaled recombinant IL-15 tested in pet dogs with metastatic lung disease from osteosarcoma or melanoma

A protein that the body naturally produces could become an important new immunotherapy drug in the cache of cancer-fighting tools available to oncologists.

9 Jun 2022

Genomic analysis provides a deeper understanding of DCIS biology

A new study led by the global Cancer Grand Challenges PRECISION team, including researchers from The University of Texas MD Anderson Cancer Center, shifts the long-held belief that all invasive breast cancers following ductal carcinoma in situ (DCIS) arise from the original DCIS lesion.

9 Jun 2022

Aspirin changes the way colorectal cancer cells evolve over time, study reveals

Cancer starts when cells start dividing uncontrollably. Scientists have known that taking aspirin can help protect against the development of colorectal cancer – cancer afflicting the colon or rectum – but the exact reason aspirin has this effect has been mostly a mystery.

9 Jun 2022

Cryo-EM helps scientists to decipher the structure of a key part of RNA degradation machinery

In biology, getting rid of stuff can be just as important as making it. A buildup of cells, proteins, or other molecules that are no longer needed can cause problems, so living things have evolved several ways to clean house.

9 Jun 2022

Infiltrating gliomas are shaped by genetic evolution and microenvironment, finds study

Researchers have discovered that infiltrating gliomas, a common brain and spinal cord tumor, are shaped by their genetic evolution and microenvironment, a finding that could lead to more targeted treatments.

9 Jun 2022

Cancer News and Research

Latest Cancer News and Research

Gut microbiome may be the "black box" of nutrition research

Scientists discover novel species of betapolyomavirus in Kenya

New machine learning algorithm finds a gene signature characteristic of tumors

New statement on best practice recommendations for the care of women experiencing menopause

New molecule kills a broad spectrum of hard-to-treat cancers

Androgens contribute to sex bias in bladder cancer

Proteomic analysis of 2002 tumors reveals 11 distinct pan-cancer molecular subtypes

Stress protein in fibroblasts appears to be an attractive cancer drug target

Using a harmless amoeba to protect children from dangerous infections

Creating CAR T cells without an immune brake

CDC announces first-year funding of $215 million for three national programs to prevent and control cancer

Rehabilitation program via telehealth to help regional and rural women recovering from gynecological cancer

Exploring the impact of climate change on lymphedema symptoms

Research reveals why many cancers are vulnerable to FDA-approved IDH1 inhibitors

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines

Inhaled recombinant IL-15 tested in pet dogs with metastatic lung disease from osteosarcoma or melanoma

Genomic analysis provides a deeper understanding of DCIS biology

Aspirin changes the way colorectal cancer cells evolve over time, study reveals

Cryo-EM helps scientists to decipher the structure of a key part of RNA degradation machinery

Infiltrating gliomas are shaped by genetic evolution and microenvironment, finds study

Understanding the DNA Damage Response in Innate Immunity eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in